+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Medical Perfusion Technology Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technique, Organ Type; Component

  • PDF Icon

    Report

  • 120 Pages
  • April 2021
  • Region: North America
  • The Insight Partners
  • ID: 5316861
UP TO OFF until Mar 31st 2024
The North America medical perfusion technology market is expected to reach US$ 403.8 million by 2027 from US$ 288.2 million in 2019. The market is estimated to grow at a CAGR of 4.4% from 2020 to 2027.

Factors such as rising prevalence of cardiovascular conditions and increasing practice of organ transplantation are anticipated to drive the market. However, the market is expected to experience slow growth during the forecast period, owing to the expensive organ transplant surgeries.

Cardiovascular diseases (CVDs) are the disorders of the heart and blood vessels, which include cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Some of the major risk factors that leads to the death and difficulties are tobacco consumption, unhealthy diet, and physical inactivity. CVDs are the leading cause of deaths across the world. Along with the lifestyle and habit, age factor is also a main reason for increasing prevalence of cardiovascular diseases. The aging population commonly shows the structural and functional alteration of vessels accumulation throughout their life, which leads to the risk of cardiovascular diseases. According to a study published by the Centers for Disease Control and Prevention (CDC) in 2020, heart disease causes death of an estimated 655,000 Americans each year. Moreover, according to a study published by the World Health Organization (WHO) in 2020, around 17.9 million people across the world die because of cardiovascular diseases. Further, the coronary heart disease (CHD) contributes to the majority of CVD deaths, which is further followed by stroke and heart failure.

Such massive prevalence and death rate due to cardiovascular conditions is anticipated to drive the adoption of perfusion technologies across the region. These devices help to bypass the function of the heart and lung during the heart surgery and maintain the continuity of blood and oxygen circulation in the body. This benefit offered by perfusion technology is likely to have a positive impact on its adoption.

The COVID-19 outbreak is challenging communities, relief organizations, and healthcare systems throughout the world. The death toll is rising exponentially. Moreover, diversion of resources from pharmaceutical drugs development to coronavirus treatment, ventilators, and nasal swabs is likely to hamper overall productivity of the cell-based research activities during the forecast period. In the more severe cases of the respiratory illness, patients may require specialist respirators to take over the role of the lungs. These respirators are in short supply, along with medical personnel, hospital space, and other personal safety equipment required to treat patients. However, some of the companies are expected to involve in the validating the feasibility of drug delivery in COVID-19. These factors likely to have an impact on the medical perfusion technology market.

Based on technique, the North America medical perfusion technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held the largest market share in 2019, whereas the normothermic machine perfusion segment is anticipated to register the highest CAGR in the market during the forecast period.

In terms of organ type, the North America medical perfusion technology market is segmented into heart, lung, kidney, liver, and others. The kidney segment held the largest market share in 2019, whereas the heart segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on component, the North America medical perfusion technology market is segmented into perfusion pumps, oxygenators, heart-lung machines, monitoring systems, cannulas, and others. The oxygenators segment held the largest market share in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the North America medical perfusion technology market are the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), among others.
Frequently Asked Questions about the North American Medical Perfusion Technology Market

What is the estimated value of the North American Medical Perfusion Technology Market?

The North American Medical Perfusion Technology Market was estimated to be valued at $288.2 Million in 2019.

What is the growth rate of the North American Medical Perfusion Technology Market?

The growth rate of the North American Medical Perfusion Technology Market is 4.4%, with an estimated value of $403.8 Million by 2027.

What is the forecasted size of the North American Medical Perfusion Technology Market?

The North American Medical Perfusion Technology Market is estimated to be worth $403.8 Million by 2027.

Who are the key companies in the North American Medical Perfusion Technology Market?

Key companies in the North American Medical Perfusion Technology Market include Medtronic, LivaNova PLC, Terumo Corporation, XVIVO Perfusion, OrganOx Limited, Waters Medical Systems LLC, TransMedics, Organ Recovery Systems, Xenios AG and Fresenius Medical Care company.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Medical Perfusion Technology Market - By Technique
1.3.2 Medical Perfusion Technology Market - By Organ Type
1.3.3 Medical Perfusion Technology Market - By Component
1.3.4 North America Medical Perfusion Technology Market - By Country
2. North America Medical Perfusion Technology Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Medical Perfusion Technology Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Medical Perfusion Technology Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Medical Perfusion Technology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Conditions
5.1.2 Increasing Practice of Organ Transplantation
5.2 Market Restraints
5.2.1 Expensive Organ Transplant Surgeries
5.3 Market Opportunities
5.3.1 Growth Opportunities in Emerging Nations
5.4 Future Trends
5.4.1 Perfusion Instruments for Cell-based Research Activities
5.5 Impact Analysis
6. Medical Perfusion Technology Market - North America Analysis
6.1 North America Medical Perfusion Technology Market Revenue Forecasts and Analysis
7. North America Medical Perfusion Technology Market Analysis and Forecasts To 2027 - By Technique
7.1 Overview
7.2 Medical Perfusion Technology Market Share, by Technique, 2019 and 2027 (%)
7.3 Hypothermic Machine Perfusion
7.3.1 Overview
7.3.2 Hypothermic Machine Perfusion: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (US$ Million)
7.4 Normothermic Machine Perfusion
7.4.1 Overview
7.4.2 Normothermic Machine Perfusion: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (US$ Million)
8. North America Medical Perfusion Technology Market Analysis and Forecasts To 2027- By Organ Type
8.1 Overview
8.2 Medical Perfusion Technology Market Share, by Organ Type, 2019 and 2027 (%)
8.3 Heart
8.3.1 Overview
8.3.2 Heart: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (USD Million)
8.4 Lung
8.4.1 Overview
8.4.2 Lung: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (USD Million)
8.5 Kidney
8.5.1 Overview
8.5.2 Kidney: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (USD Million)
8.6 Liver
8.6.1 Overview
8.6.2 Liver: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (USD Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Medical Perfusion Technology Market- Revenue and Forecast to 2027 (USD Million)
9. North America Medical Perfusion Technology Market Analysis and Forecasts To 2027- By Component
9.1 Overview
9.2 Medical Perfusion Technology Market, By Component 2019 & 2027 (%)
9.3 Perfusion Pumps Market
9.3.1 Overview
9.3.2 Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Oxygenators market
9.4.1 Overview
9.4.2 Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Heart Lung Machine Market
9.5.1 Overview
9.5.2 Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Monitoring Systems market
9.6.1 Overview
9.6.2 Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Cannulas Market
9.7.1 Overview
9.7.2 Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Medical Perfusion Technology Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America: Medical Perfusion Technology Market
10.1.1 Overview
10.1.2 North America: Medical Perfusion Technology Market, by Country, 2019& 2027 (%)
10.1.2.1 US: Medical Perfusion Technology Market - Revenue and Forecast to 2027 (USD Million)
10.1.2.1.1 US: Medical Perfusion Technology Market - Revenue and Forecast to 2027 (USD Million)
10.1.2.1.2 US: Medical Perfusion Technology Market, by Technique, 2018-2027 (USD Million)
10.1.2.1.3 US: Medical Perfusion Technology Market, by Organ Type, 2018-2027 (USD Million)
10.1.2.1.4 US: Medical Perfusion Technology Market, by Component, 2018-2027 (USD Million)
10.1.2.2 Canada: Medical Perfusion Technology Market - Revenue and Forecast to 2027 (USD Million)
10.1.2.2.1 Canada: Medical Perfusion Technology Market - Revenue and Forecast to 2027 (USD Million)
10.1.2.2.2 Canada: Medical Perfusion Technology Market, by Technique, 2018-2027 (USD Million)
10.1.2.2.3 Canada: Medical Perfusion Technology Market, by Organ Type, 2018-2027 (USD Million)
10.1.2.2.4 Canada: Medical Perfusion Technology Market, by Component, 2018-2027 (USD Million)
10.1.2.3 Mexico: Medical Perfusion Technology Market - Revenue and Forecast to 2027 (USD Million)
10.1.2.3.1 Mexico: Medical Perfusion Technology Market - Revenue and Forecast to 2027 (USD Million)
10.1.2.3.2 Mexico Medical Perfusion Technology Market, by Technique - Revenue and Forecast to 2027 (USD Million)
10.1.2.3.3 Mexico Medical Perfusion Technology Market, by Organ Type - Revenue and Forecast to 2027 (USD Million)
10.1.2.3.4 Mexico Medical Perfusion Technology Market, by Component - Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Medical Perfusion Technology Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 LivaNova PLC
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Terumo Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 XVIVO Perfusion
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 OrganOx Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Waters Medical Systems LLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 TransMedics
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Organ Recovery Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Xenios AG - a Fresenius Medical Care company
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About the Publishers
14.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Medtronic
  • LivaNova PLC
  • Terumo Corporation
  • XVIVO Perfusion
  • OrganOx Limited
  • Waters Medical Systems LLC
  • TransMedics
  • Organ Recovery Systems
  • Xenios AG - Fresenius Medical Care company